drugset / Trial / NCT00513981

High-Dose Methotrexate in Treating Young Patients With Solid Tumors

NCT00513981

Phase 1 Completed 36 enrolled Children's Cancer and Leukaemia Group
Open-labelTreatment

Summary

RATIONALE: Drugs used in chemotherapy, such as high-dose methotrexate work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing. Chemoprotective drugs, such as leucovorin calcium, may protect normal cells from the side effects of chemotherapy. PURPOSE: This phase I trial is studying the side effects, best way to give, and best dose of high-dose methotrexate in treating patients with solid tumors.

Timeline

Start
2007-03
Primary completion
2008-03
Completion
2009-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Methotrexate Small molecule 6000 mg/m2 Intravenous
Background Leucovorin Small molecule Intravenous